Is the Novartis CEO Getting a Pay Cut?
Source Many people may complain about the gap between ceo compensation and the rest of the world, but the Swiss are doing more than grumbling. A nationwide vote is planned for March 3 on an initiative that would look to level the playing field by giving citizens a chance to decide whether shareholders should have […]
Read More »Category : News
FDA quietly steps in to inspect a second Massachusetts pharmacy
Federal regulators have quietly stepped in to inspect another Massachusetts pharmacy similar to New England Compounding Center, the Framingham compounding company blamed for the national fungal meningitis outbreak that has sickened more than 660 people and killed 40. Inspectors from the US Food and Drug Administration recently joined state officials in their ongoing surprise inspections […]
Read More »Category : News
Merck Worker Claims She Was Fired for Age
Source There is a refrain in a famous song by The Beatles that asks ‘Will you still need me? Will you still feed me? When I’m 64?’ For Geraldine Greco, a former Merck employee, the answer was a resounding no, at least according to an age discrimination lawsuit filed recently by the 62-year-old administrative assistant. […]
Read More »Category : News
MA Tries To Get Tougher on Compounders
source In the wake of the fungal meningitis scandal that regulators have traced to the New England Compounding Center, Massachusetts Governor Deval Patrick late last week proposed new laws in hopes of preventing another debacle. So far, the outbreak has led to 656 cases and 39 deaths in 19 states (see this and this). […]
Read More »Category : News
J&J Sells Rolaids Brand to Sanofi. What Next?
Source For the past two weeks, there was rising speculation that Johnson & Johnson may have unloaded a sizable chunk of its troubled consumer health business to Sanofi, which owns Chattem, another player in the over-the-counter business. Why? The US Federal Trade Commission web site noted that a deal had been approved, but details were […]
Read More »Category : News
Closure of Ameridose, Westborough drug company, extended 6 weeks in meningitis probe
A Westborough drug company with the same owners as the Framingham specialty pharmacy at the center of the national fungal meningitis outbreak will remain closed until at least Feb. 22, public health regulators said Thursday. Ameridose LLC, which voluntarily ceased operations Oct. 10, will remain shuttered while a joint investigation by state and federal authorities […]
Read More »Category : News
KV Pharma Loses Battle Over Makena
Source KV Pharmaceutical may have emerged from bankruptcy in hopes of marketing still more of its Makena treatment for reducing the risk of premature births. But the troubled little drugmaker, which has consistently locked horns with the FDA, last week lost another battle with the agency over its efforts to fend off competition to its […]
Read More »Category : News
Pharmaceutical manufacturer Exela to expand Lenoir plant
Exela Pharma Sciences, a pharmaceutical manufacturer, said Thursday it will expand its plant in Lenoir, adding 38 jobs and spending $8.5 million on capital investments over three years. The company is eligible for an $189,000 grant from the One North Carolina Fund, as well as local incentives. Exela Pharma Sciences is a wholly owned subsidiary […]
Read More »Category : News
FDA Is Really Going to Issue Rules for Social Media
source Remember how the FDA, more than once, insisted that social media guidelines were on the way? This has become akin to Waiting For Godot. The agency, however, may yet get its act together. But when? And how might this play out? Brian Reid, a director at WCG, an integrated communications firm, and a […]
Read More »Category : News
AbbVie Exists – Now What?
source It is now official – AbbVie exists. For those who may not recall, AbbVie is the so-called research-based pharma that has been spun off by Abbott Laboratories and features a portfolio of existing medicines, such as Humira and Synthroid, along with a pipeline of some 20 compounds in Phase II or Phase III development. […]
Read More »Category : News
